GIP and Insulin resistance: Treatment of obese mice with GIP receptor (GIPR) antagonist leads to rapid improvement in β‐cell function and glucose tolerance through alleviation of insulin resistance,60 but it remains to be investigated whether the effects of blocking GIP in humans are similar to those observed in mice.